Vulvar squamous cell carcinoma (VSCC), a rare gynecologic malignancy, has been rising in incidence. Molecular classification on the basis of human papilloma virus (HPV) and tumor protein 53 (p53) ...
Precision medicine is looking increasingly promising in advanced vulvar squamous cell carcinomas (VSCCs), which make up 90% of vulvar cancers. The emergence of molecular stratification provides ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Dave Coulier recently revealed another cancer diagnosis, mere months after recovering from Stage 3 non-Hodgkin’s lymphoma ...
Gynecological cancers affect the reproductive organs of people who were assigned female at birth (AFAB). They include cancers of the: Cervix Ovaries Uterus Vagina Vulva A sixth type is a very rare ...
A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment. This therapy is the first ...
Patients enrolled in a single-arm phase II study. Pretreatment inguinal-femoral nodal assessment was performed. Sixty-four Gy IMRT was prescribed to the vulva, with 50-64 Gy delivered to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback